In agreement with our findings, Ang et al. reported upregulation of PCs, including PC ae C42:4, in plasma of mice bearing BRAF mutant melanoma xenografts, which was reversed by MEK inhibitor treatment [57]. The gene discussed is BRAF; the disease is melanoma.